| 1 |
Increased
DNA
strand breaks and neoplastic transformation in human bladder cells treated with pioglitazone |
|
|
| Zülal Atli Sekeroglu,Vedat Sekeroglu,Seval Kontas Yedier,Emre Ilkun,Louis S. Liou |
|
| Environmental and Molecular Mutagenesis. 2021; 62(2): 143 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
A retrospective study to assess the risk of bladder cancer in type-2 diabetic patients treated with pioglitazone |
|
|
| Prabhat Agrawal,Apoorva Jain,Ashish Gautam,AshwiniKumar Nigam,Nikhil Pursnani,Maaz Farooqui |
|
| Perspectives in Clinical Research. 2019; 0(0): 0 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Fighting Type-2 Diabetes: Present and Future Perspectives |
|
|
| Cai-Guo Yu,Ying Fu,Yuan Fang,Ning Zhang,Rong-Xin Sun,Dong Zhao,Ying-Mei Feng,Bao-Yu Zhang |
|
| Current Medicinal Chemistry. 2019; 26(10): 1891 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Pioglitazone and risk of bladder cancer in type 2 diabetes mellitus patients: A systematic literature review and meta-analysis of observational studies using real-world data |
|
|
| Mohammad Adil,Rashid Ali Khan,Pinaki Ghosh,Shiva Kumar Venkata,Amit Dattatraya Kandhare,Manju Sharma |
|
| Clinical Epidemiology and Global Health. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Global and Regional Effects of Bladder Cancer Risk Associated with Pioglitazone Therapy in Patients with Diabetes |
|
|
| Hua Qu,Yi Zheng,Yuren Wang,Rui Zhang,Xiongzhong Ruan,Gangyi Yang,Zhenqi Liu,Hongting Zheng |
|
| Scientific Reports. 2017; 7(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis |
|
|
| Elena Filipova,Katya Uzunova,Krassimir Kalinov,Toni Vekov |
|
| Diabetes Therapy. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future |
|
|
| Melissa A. Davidson,Donald R. Mattison,Laurent Azoulay,Daniel Krewski |
|
| Critical Reviews in Toxicology. 2017; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Methods for determining neurotransmitter metabolism markers for clinical diagnostics |
|
|
| I. A. Veselova,E. A. Sergeeva,M. I. Makedonskaya,O. E. Eremina,S. N. Kalmykov,T. N. Shekhovtsova |
|
| Journal of Analytical Chemistry. 2016; 71(12): 1155 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
